Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry. Issue 3 (1st August 2006)

• Record Type: Journal Article
• Authors: Lopez-Beltran, Antonio; Requena, Maria J; Alvarez-Kindelan, Jose; Quintero, Ana; Blanca, Ana; Montironi, Rodolfo
• Is Part Of: Journal of clinical pathology. Volume 60:Issue 3(2007)
• Page Start: 332
• Page End: 335
• Publication Date: 2006-08-01
• Subjects: SqD, squamous differentiation; Pathology -- Periodicals; Pathology, Molecular -- Periodicals; 616.0705
• DOI: 10.1136/jcp.2006.038802
• Languages: English
• ISSNs: 0021-9746

Abstract

Abstract : Squamous differentiation (SqD) is variably present in urinary tract tumours, but its significance remains unclear. In this study, SqD was assessed by immunohistochemistry using the monoclonal antibody Mac387 in 145 urothelial tumours (bladder, n = 115; renal pelvis, n = 30). Mac387 detects the myelomonocytic L1 antigen; a member of the calgranulin family shared by epithelial cells and keratinocytes. L1 antigen was shown in SqD in urothelial carcinomas of the bladder or the renal pelvis, including 11 cases with focal SqD unrecognised by conventional analysis. SqD is more frequent in renal pelvic tumours (p = 0.027) and increases with grade/stage mainly in bladder carcinoma (grade, p = 0.05; stage, p = 0.005). Stage Ta/T1 bladder carcinomas with SqD recurred more (p = 0.021). In conclusion, Mac387 efficiently shows SqD in urothelial tumours.